tiprankstipranks
Trending News
More News >
Alibaba Health Information Technology (HK:0241)
:0241
Hong Kong Market
Advertisement

Alibaba Health Information Technology (0241) Financial Statements

Compare
19 Followers

Alibaba Health Information Technology Financial Overview

Alibaba Health Information Technology's market cap is currently HK$80.43B. The company's EPS TTM is HK$0.06563402460000001; its P/E ratio is 52.23; Alibaba Health Information Technology is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is HK$0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 30.60B¥ 27.03B¥ 26.76B¥ 20.58B¥ 15.52B
Gross Profit¥ 7.43B¥ 5.90B¥ 5.70B¥ 4.11B¥ 3.62B
Operating Income¥ 1.58B¥ 717.40M¥ -51.50M¥ -1.10B¥ 37.47M
EBITDA¥ 1.62B¥ 999.05M¥ -24.48M¥ -188.12M¥ 52.14M
Net Income¥ 1.43B¥ 883.48M¥ 535.65M¥ -265.56M¥ 348.59M
Balance Sheet
Cash & Short-Term Investments¥ 8.10B¥ 9.55B¥ 10.92B¥ 10.55B¥ 11.64B
Total Assets¥ 21.18B¥ 19.71B¥ 20.75B¥ 19.20B¥ 17.74B
Total Debt¥ 35.52M¥ 82.17M¥ 77.80M¥ 135.41M¥ 37.74M
Net Debt¥ -2.18B¥ -9.47B¥ -10.84B¥ -10.41B¥ -11.60B
Total Liabilities¥ 4.87B¥ 5.19B¥ 5.60B¥ 5.13B¥ 3.46B
Stockholders' Equity¥ 16.31B¥ 14.54B¥ 15.17B¥ 14.10B¥ 14.30B
Cash Flow
Free Cash Flow¥ 1.38B¥ 1.06B¥ 250.08M¥ 409.43M¥ 992.35M
Operating Cash Flow¥ 1.40B¥ 1.08B¥ 255.69M¥ 424.36M¥ 1.01B
Investing Cash Flow¥ -2.60B¥ -4.88B¥ -532.44M¥ 1.87B¥ -4.96B
Financing Cash Flow¥ -72.52M¥ -1.98B¥ -111.28M¥ -58.63M¥ 8.92B
Currency in CNY

Alibaba Health Information Technology Earnings and Revenue History

Alibaba Health Information Technology Debt to Assets

Alibaba Health Information Technology Cash Flow

Alibaba Health Information Technology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis